REDMOND, Wash. - Microsoft Corporation (NASDAQ:MSFT), the $3.2 trillion tech giant with a "GREAT" financial health score according to InvestingPro, has recast its financial statements from the previous fiscal year to align with recent changes in its operating segments, the company announced in a Form 8-K filing with the Securities and Exchange Commission today.
The adjustments, which do not represent a restatement of previously issued financial statements, reflect changes to the company's segment reporting that were first announced in August 2024.
These changes primarily consolidate the commercial components of Microsoft 365 into the Productivity and Business Processes segment, a key driver of the company's impressive 16.4% revenue growth over the last twelve months. The transition to the new segment structure will begin in fiscal year 2025.
For more recent developments, stakeholders are referred to Microsoft's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. The recast financial information can be found in Exhibit 99.1 of the Form 8-K, which incorporates updates to the Business and Financial Statements sections of the 2024 Form 10-K.
Microsoft's common stock is traded on the Nasdaq under the trading symbol MSFT. The company, which has maintained dividend payments for 22 consecutive years with a recent 10.7% dividend growth rate, is currently trading near its InvestingPro Fair Value.
The company's headquarters are located at One Microsoft Way, Redmond, Washington 98052-6399. For detailed analysis and 15 additional ProTips about Microsoft's financial outlook, visit InvestingPro, where you can access comprehensive Pro Research Reports covering what really matters for smarter investment decisions.
In other recent news, Microsoft Corporation reported a 16% year-on-year increase in Q1 FY2025 revenue, reaching $65.6 billion. The company's cloud unit, Microsoft Cloud, also reported robust performance, with revenues surpassing $38.9 billion, marking a 22% increase from the previous year.
Analyst firms, including TD Cowen, Citi, Mizuho (NYSE:MFG), and Goldman Sachs, have maintained their positive ratings on Microsoft's stock, reflecting confidence in the company's growth potential, particularly in the realm of AI technology. Microsoft's AI business is expected to exceed a $10 billion annual run rate in the upcoming quarter.
In the healthcare sector, Tevogen Bio has partnered with Microsoft to expedite the target identification process for their oncology product, TVGN 920, using AI and cloud technologies. In corporate developments, Asterion Industrial Partners, in collaboration with Telefonica (NYSE:TEF), sold Nabiax, a Spanish data center operator, to Aermont Capital.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.